United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet needs of patients with chronic and life-threatening conditions. The company's mission is to provide transformative therapies for diseases such as pulmonary arterial hypertension and organ transplantation. United Therapeutics employs a strategy centered on research and development, leveraging advanced technologies and collaborations to enhance patient outcomes. Through its commitment to innovation and patient care, United Therapeutics aims to improve the quality of life for individuals suffering from serious health challenges.

UNITED THERAPEUTICS CORP

United Therapeutics, co-founded and led by Martine Rothblatt, is poised for significant engagement at the upcoming eMerge Americas Conference + Expo on March 27-28, 2025, in Miami. Rothblatt, an influential figure in both technology and health, will speak at this event designed to foster innovation in the medical sector.

United Therapeutics to Showcase Innovations in Health Technology at eMerge Americas Conference Amid Strong Performance in PAH and Cancer Treatment Markets